# DESCRIPTION

## FIELD OF INVENTION

- define field of hematopoietic stem cells

## BACKGROUND OF THE INVENTION

- discuss limitations of umbilical cord blood-derived hematopoietic stem cells

## SUMMARY OF THE INVENTION

- motivate Musashi-2 (MSI2) overexpression
- describe MSI2-induced pro-self-renewal phenotypes
- summarize MSI2-RNA interactions and AHR signaling
- outline methods for increasing self-renewal and expansion of HSPCs

## DETAILED DESCRIPTION

- define terms and concepts related to hematopoietic stem cells and progenitor cells

### Methods of Expanding HSPCs

- describe method of increasing self-renewal and/or expansion of HSPCs by inhibiting CYP1B1
- describe method of increasing self-renewal and/or expansion of HSPCs by increasing MSI2 expression or activity
- describe effects of expanding HSPCs on frequency and/or number of HSPCs
- describe testing population of cells for expression of biomarkers
- describe separating HSPCs from population of cells using positive or negative selection techniques
- describe biomarkers for human hematopoietic stem cells and progenitor cells
- describe methods of inhibiting CYP1B1 and increasing MSI2 expression or activity

### Expanded HSPCs for Therapeutic Use

- describe use of expanded HSPCs for transplantation or therapeutic use in subjects with hematopoietic disorders, malignancies, autoimmune diseases, and/or immun

### Compositions

- define composition embodiments

### Methods of Culturing Leukemic Cells

- describe culturing methods

### Example 1: Inhibition of Cytochrome P450 1B1 Oxidase Causes Expansion of Hematopoietic Stem and Progenitor Cells

- describe mouse and human cell isolation procedures
- outline lentivirus production and western blot validation
- detail cord blood transduction and clonogenic progenitor assays
- summarize cell cycle, apoptosis, and intracellular flow cytometry assays
- describe RNA-sequencing data processing and analysis
- outline GSEA and iRegulon AHR target prediction, and DMAP population comparisons
- Analyze gene expression with UM171 and SR1 treatment
- Identify AHR transcription factor binding sites
- Analyze human chimerism in NSG mice
- Perform HSC and STRC xenotransplantations
- Prepare CLIP-seq library and perform UV cross-linking immunoprecipitation sequencing
- Map CLIP-seq reads and identify clusters
- Perform gene ontology analysis and de-novo motif and conservation analysis
- Perform immunofluorescence, luciferase reporter gene assay, and statistical analysis

### Results & Discussion

- investigate MSI2 role in human HSPC self-renewal
- demonstrate MSI2 overexpression promotes HSPC self-renewal
- show MSI2 knockdown reduces self-renewal in early progenitors and HSCs
- analyze RNA-seq data to identify MSI2-induced transcriptional changes
- identify Cytochrome P450 1B1 Oxidase as a key target of MSI2
- demonstrate MSI2 OE expands HSPCs through AHR signaling attenuation

### Example 2: CYPB1 Knockdown Increases the Number of CD34 Marked HSPCs

- demonstrate CYP1B1 knockdown increases HSPC activity

### Example 3: High Throughput Screen to Test CYP Family Inhibitors

- identify compounds that promote HSPC activity

### Example 3: Combinatorial HSPC Promoting Effects of SR1 with TMS

- demonstrate combinatorial HSPC promoting effects of SR1 with TMS

